Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Dec 1;82(4):392–398. doi: 10.1097/QAI.0000000000002149

Figure 1.

Figure 1.

Simulated pharmacokinetic profile of raltegravir for typical individual treated by dose regimen scenario 10: 1.5 mg/kg once daily from day-1 to day-7, 3 mg/kg twice daily from day-8 to day-28 and 6 mg/kg twice daily from day-29 to day-42.